J Clin Oncol 40 (25): 2946-2956, 2022.[PUBMED Abstract] Hortobagyi GN, Stemmer SM, Burris HA, et al.: Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.
N Engl J Med 386 (10): 942-950, 2022.[PUBMED Abstract] Slamon DJ, Neven P, Chia S, et al.: Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3.
J Clin Oncol 36 (24): 2465-2472, 2018.[PUBMED Abstract] Slamon DJ, Neven P, Chia S, et al.: Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.